Posted inBiotechnology
Tutorial Explains How to Use Large Language Models in Medical Research
Frontier large language models are moving from lab demonstrations to practical tools for healthcare, with systems such as GPT-5, Claude…
Posted inBiotechnology
Recycling US food waste cuts climate and nutrient pollution, but risks soil plastic buildup
Diverting household and commercial food scraps from landfills toward composting and anaerobic digestion can cut greenhouse-gas emissions and support a…
Posted inBiotechnology
Pathology-CoT Trains Visual Chain-of-Thought Agents Using Expert Whole-Slide Diagnoses
Whole-slide imaging (WSI) promises pathology at scale, but today’s diagnostic AI still struggles with the messy, interactive way experts actually…
Posted inBiotechnology
Cracking-Assisted Transfer Printing Enables High-Resolution Full-Color Quantum Dot LEDs
A team of researchers has unveiled a fabrication route that could push quantum dot light-emitting diodes (QLEDs) toward sharper, full-colour…
Posted inBiotechnology
Mitochondrial tRNA Biogenesis and Modifications Linked to Human Disease
Mitochondria rely on transfer RNAs that have undergone extreme evolutionary change—yet still sustain protein synthesis inside the organelle. A new…
Posted inBiotechnology
Amgen sheds around 40 staffers amid continuing struggles
Amgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s…
Posted inBiotechnology
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as potential…
Posted inBiotechnology
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
In vivo gene editing outfit Scribe Therapeutics has priced its IPO at $128.7 million, surpassing the $96 million goal set…
Posted inBiotechnology
Chutes & Ladders—Biogen R&D vet gets in Formation
AI-focused Formation Bio has found a new chief scientist with extensive experience in biotech, Big Pharma and academia. Michael Ehlers,…
Posted inBiotechnology
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
Whether it's looming tariff threats or the rise of China, you need a truly global view to navigate today's biopharma…